Hong Ying, Song Si-Jia, Liu Bo, Hassanpour Kiana, Zhang Chun, Loewen Nils
Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.
Department of Ophthalmology, School of Medicine, University of Pittsburgh, PA 15213, USA.
Int J Ophthalmol. 2019 May 18;12(5):784-788. doi: 10.18240/ijo.2019.05.13. eCollection 2019.
To evaluate the efficiency and safety of micropulse laser trabeculoplasty (MLT) for primary open angle glaucoma (POAG) patients.
Retrospective study. POAG patients undergoing MLT in Peking University Third Hospital from June 2016 to November 2017. Seventy-two eyes of 72 POAG patients were enrolled. Only one eye of each patient was treated by MLT. The intraocular pressure (IOP) before MLT and at 1d, 1, 4, 12 and 24wk and glaucoma medication before and after treatment were compared.
The IOP was 20.6±5.9 mm Hg before MLT and 20.8±6.8 mm Hg at 2h after MTL. The IOP at 1d, 1, 4, 12 and 24wk was 17.9±4.4, 18.0±4.3, 17.5±3.4, 17.0±2.7, and 16.5±2.9 mm Hg, respectively. The IOP before and after MLT demonstrated a statistically significant difference by ANOVA analyses (=5.797, <0.001). Least significant difference -tests showed there was no statistically significant difference between pre-MLT IOP within 2h after MLT (=0.207). The statistically significant difference was confirmed between the pre-MLT IOP at 1d, 1, 4, 12 and 24wk after MLT (=0.006, 0.009, 0.001, <0.001, <0.001, respectively). The number of glaucoma medications before MLT was 1.7±1.4 and 1.5±1.4 24wk after MLT with a significantly statistical difference (=2.219, =0.031).
MLT is effective and safe for POAG patients. No patient experienced IOP spikes after MLT. The IOP 6mo after treatment decreased significantly with less glaucoma medication.
评估微脉冲激光小梁成形术(MLT)治疗原发性开角型青光眼(POAG)患者的有效性和安全性。
回顾性研究。选取2016年6月至2017年11月在北京大学第三医院接受MLT治疗的POAG患者。纳入72例POAG患者的72只眼。每位患者仅一只眼接受MLT治疗。比较MLT治疗前及治疗后1天、1周、4周、12周和24周的眼压(IOP)以及治疗前后的青光眼用药情况。
MLT治疗前眼压为20.6±5.9 mmHg,MTL治疗后2小时眼压为20.8±6.8 mmHg。治疗后1天、1周、4周、12周和24周的眼压分别为17.9±4.4、18.0±4.3、17.5±3.4、17.0±2.7和16.5±2.9 mmHg。通过方差分析(=5.797,<0.001),MLT治疗前后眼压差异有统计学意义。最小显著差异检验显示MLT治疗后2小时内治疗前眼压之间无统计学显著差异(=0.207)。MLT治疗后1天、1周、4周、12周和24周治疗前眼压之间差异有统计学意义(分别为=0.006、0.009、0.001、<0.001、<0.001)。MLT治疗前青光眼用药次数为1.7±1.4,治疗后24周为1.5±1.4,差异有统计学意义(=2.219,=0.031)。
MLT治疗POAG患者有效且安全。MLT治疗后无患者出现眼压峰值。治疗6个月后眼压显著降低,青光眼用药减少。